|
|
|
Issue Open Date
|
28-Sep-17
|
|
|
|
Issue Closing Date
|
05-Oct-17
|
|
|
|
Application Money
|
100
|
|
|
|
Allotment Money
|
|
|
|
|
|
|
|
Price Band
|
36
-
|
|
|
|
Minimium Application No.
|
3000
|
|
|
|
Issue Size (Shares)
|
2376000
|
|
|
|
Market Lot
|
1
|
|
|
|
|
|
Objective
|
|
OBJECTS OF THE ISSUEThe Issue comprises of fresh issue of 23,76,000 Equity Shares by our Company aggregating up to Rs.855.36 Lakhs (“Fresh Issue”).Our Company proposes to utilize the Net Proceeds from the issue towards the following objects:1. Setting up a new Choloro Compound derivatives manufacturing plant with a proposed capacity of200 MTPA at Ankleshwar GIDC Gujarat (“Project”);2. General Corporate Purposes
|
|
|
|
|
|
|
Category
|
No. of Shares
|
No. of Shares
|
Subscription Ratio
|
|
|
Offered / Reserved |
Bid For |
|
|
Non-Institutional Investors
|
|
|
|
|
Qualified Institutional Buyers
|
|
|
|
|
Retail Individual Investors
|
|
|
|
|
|
|
|
Business Description
OVERVIEWOur Company was originally incorporated as “Shree Ganesh Remedies Private Limited” at Ahmedabad,Gujarat as a Private Limited Company under the provisions of Companies Act, 1956 vide Certificate ofIncorporation dated April 27, 1995 bearing registration number 025661 issued by Assistant Registrar ofCompanies, Gujarat, Dadra & Nagar Haveli. Subsequently, our Company was converted into a PublicLimited Company pursuant to special resolution passed by the shareholders at the Extraordinary GeneralMeeting held on July 12, 2017 and fresh certificate of incorporation consequently upon change of name wasissued by Registrar of Companies, Gujarat, Ahmedabad dated July 28, 2017 and name of our Company waschanged to “Shree Ganesh Remedies Limited”Our Company is as ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company andis engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride andspecialty fine chemicals for pharmaceutical industry. We manufacture products relating to antipsychotic,antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral.The manufacturing process is supported by Total Quality Management techniques and is supervised throughvarious quality control equipment’s and qualified personnel. The Products are manufactured for exportmarket and also for domestic and foreign markets. We entered the International market in the year 2006 andare on regular basis exporting our products to various countries.Our manufacturing facility is divided into three manufacturing plants namely Plant I, II and III spread across9715 square meters having different product manufacturing capabilities and process.Our Company is managed by a team of professionals headed by our Managing Director having experiencein the field of manufacturing of pharmaceuticals intermediates, bulk drugs, fine chemicals, pigments andplastics. Our Company undertakes manufacturing of products on custom research to some extent as per theproject receivedOur Company’s total revenue as restated in Financial Year 2017, 2016 and 2015 was Rs.2032.49 lakhs, Rs.1587.89 lakhs and Rs. 1698.70 lakhs, respectively. Our Company’s profit/loss after tax as restated inFinancial Year 2017, 2016 and 2015 was Rs. 261.49 lakhs, Rs. 108.35 lakhs and Rs. 127.46 lakhs,respectively.Our Company has received the following accreditations: -1. Recognized as Export House by Government of India2. 3rd prize winner at Ankleshwar Industries Association for export Performance amongst small scaleIndustrial units in GIDC, Ankleshwar for the year 2015-16Company Location and manufacturing facility:Our Registered Office and Manufacturing facility is Situated at Plot No 6011, G.I.D.C, Ankleshwar –393002, Gujarat, India.OUR PRODUCTSWe have product portfolio that consists ofSr.NoProduct Name Applications/ End use1. Di methyl amino propyl chloride HCl Dimethylaminopropyl chloride hydrochloride isused in Chloropromazine for antiphychotic2. Tr ityl chloride(TTCL) Trityl chloride (TTCL) is used as a protecting agentgenerally used in pharmaceutical Industry3. 4-C hloro 4 Fluoro Butyrophenone (CFBP) Used as Intermediates of Haloperidol antiphychotic4. M ethyl Cyclo Propane Carboxylate Acid/Acid ChlorideProduct is used to manufacture Fenopropathrin.Fenorpropathrin is widely used as pyrethroidinsectide in agriculture and household.5. 1-B romo-4-Propylheptane (BPH) Used in delmophinol as an antiseptic mouth wash6. So dium Bis (Trimethylsilyl) Amide in THF1M/2MIt is a strong base used for deprotonation reactions7. Ty ramine HCl /Base Used in Benzafibrate for Hyperlipidemia andUsed in galantamine Hbr for Alzheimer’s disease8. He xadienyl acetate(HDA) Used as flavoring agent9. Cy clo Propane Carboxylic Acid Used in Moxifloxacin as anti-viral
|
|
|
Promoter's Holding
|
|
|
|
Total Share Capital
|
5626398
|
|
|
|
Offered to Public
|
2376000
|
|
|
|
Promoter's Holding (Pre-Issue)
|
85.31
|
|
|
|
Promoter's Holding (Post-Issue)
|
62.72
|
|
|
|
|
|
|
|
|
|
|
Address |
Plot No. 6002
6003
6011 & 6012
G. I. D. C.
Bharuch
Ankleshwar,
Gujarat,
393002
Phone : 07574 976076
Email : investors@ganeshremedies.com
Website : www.ganeshremedies.com
|
|
|
Registrar |
Bigshare Services Pvt Ltd
G 10 Left Wing Amruta Village
Opp: Yashoda Hospital
Raj Bhavan Road
Somajiguda
Hyderabad
|
|
|
Listed at |
|
BSE
|
|
|
Lead Manager |
|
Fedex Securities Ltd.
|
|
|
Promoters |
Ashokkumar Kothia
Babubhai Kothia
Chandubhai Kothia
Hansaben Kothia
Hasmukh Kothia
Manubhai Kothia
Subhash Kothia
|
|
